secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2024-10-18T23:59:59+00:00
Accession:  0001640334-24-001541
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria Bioscience sets Jan 14, 2025 annual/special meeting; director nomination deadline Nov 25
--------------------------------------------------------------------------------

- Joint Annual and Special Meeting scheduled for January 14, 2025.
- Stockholder approval required for Private Placement Warrants issued in October 2024.
- Director nominee submissions due by noon ET on November 25, 2024, to Vanessa Carle.
- Submission address: vcarle@lexariabioscience.com; Schedule 14N required.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033424001541/0001640334-24-001541-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033424001541/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-24-001541

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer